You have searched for "EMA"
Showing 1-10 of 384
Our columnist shares some common Covid-19 vaccine myths he has come across, and the actual facts relating to them.
Philippines extends sympathies to Britain on Prince Philip's death; suspends use of AstraZeneca jab for people under 60
Philippine President Rodrigo Duterte expressed "deep condolences" on the passing of Prince Philip, as he cited the strong bilateral ties between the Philippines and Britain.
(Reuters) - Europe's drug regulator said on Friday that it is reviewing rare blood clots in four people in the United States who received Johnson & Johnson's COVID-19 vaccine.
SUBANG JAYA: The latest information concerning the use of the AstraZeneca vaccine will be reviewed and presented in a meeting soon, says Khairy Jamaluddin.
(Reuters) - Australia said on Friday it had ordered more alternatives for the AstraZeneca vaccine, setting back its vaccination rollout, and Hong Kong delayed deliveries of the shot amid concern about a possible very small risk of rare blood clots.
ZURICH (Reuters) - Europe's drug regulator on Wednesday said it had found a possible link between AstraZeneca's COVID-19 vaccine and very rare blood clots in adults who received the shot. Britain recommended people under 30 get an alternative COVID-19 vaccine if possible.
KUALA LUMPUR (Bernama): The government will decide on whether Malaysia can continue to use the AstraZeneca vaccine or not at the Covid-19 Vaccine Supply Access Guarantee Special Committee (JKJAV) meeting in two weeks time.
SAN JOSE (Reuters) - Costa Rica will use AstraZeneca's COVID-19 vaccine after assessing guidance from the European Medicines Agency (EMA) on the risks of possible side-effects, the health ministry said on Thursday.
PETALING JAYA: Malaysia will decide on the use of the AstraZeneca vaccine for Covid-19 following a report by the European Medicines Agency (EMA) of rare blood clots being a possible side effect, says Science, Technology and Innovation Minister Khairy Jamaluddin.
SINGAPORE (Bloomberg/Reuters/AFP): The AstraZeneca Covid-19 vaccine came under the spotlight following reports of rare blood clots, some of them fatal, among some adult vaccine recipients.